PAA
CELG

Peregrine Asset Advisers’s Celgene Corp CELG Stock Holding History

Peregrine Asset Advisers’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,664
Closed -$243K – 124
2017
Q3 		$243K Buy
+1,664
New +$227K 0.13% 74
2017
Q2 		– Sell
-61,045
Closed -$7.6M – 106
2017
Q1 		$7.6M Buy
+61,045
New +$7.31M 4.09% 8

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Peregrine Asset Advisers's CELG Position: Q4 2017 in Review

Peregrine Asset Advisers sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,664 shares — an estimated $243K sold.

Peregrine Asset Advisers first reported a position in CELG in Q1 2017 and held it in 2 quarters. The position peaked at $7.6M in Q1 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Peregrine Asset Advisers reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Peregrine Asset Advisers sold 1,664 Celgene Corp shares in Q4 2017, an estimated $243K.
  • Peregrine Asset Advisers first reported a position in Celgene Corp in Q1 2017 and held it in 2 quarters.
  • Peregrine Asset Advisers's Celgene Corp position peaked at $7.6M in Q1 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Peregrine Asset Advisers's 13F filing for Q4 2017, filed 1 Feb 2018.